Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Lin

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cureus|May 22, 2025
Systemic Lupus Erythematosus as a Risk Factor for Encapsulating Peritoneal Sclerosis: A Case ReportAabid Mohiuddin, Fawaz Hussain, Leslie Lin, et al.
Current Problems in Cancer|December 12, 2022
Folate Receptor as a Biomarker and Therapeutic Target in Solid TumorsOlivia Young, Nealie Ngo, Leslie Lin, et al.
Oncology Reviews|July 16, 2021
<i>Adenomatous polyposis</i> coli in cancer and therapeutic implicationsOlivia Noe, Louis Filipiak, Rachel Royfman, et al.
Oncology Reviews|December 19, 2022
NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian CancerMonika Devanaboyina, Jasskiran Kaur, Emma Whiteley, et al.
International Journal of Molecular Sciences|March 28, 2024
Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian CancerMorgan Bailey, Susan Morand, Rachel Royfman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cureus|May 22, 2025
Systemic Lupus Erythematosus as a Risk Factor for Encapsulating Peritoneal Sclerosis: A Case ReportAabid Mohiuddin, Fawaz Hussain, Leslie Lin, et al.
Current Problems in Cancer|December 12, 2022
Folate Receptor as a Biomarker and Therapeutic Target in Solid TumorsOlivia Young, Nealie Ngo, Leslie Lin, et al.
Oncology Reviews|July 16, 2021
<i>Adenomatous polyposis</i> coli in cancer and therapeutic implicationsOlivia Noe, Louis Filipiak, Rachel Royfman, et al.
Oncology Reviews|December 19, 2022
NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian CancerMonika Devanaboyina, Jasskiran Kaur, Emma Whiteley, et al.
International Journal of Molecular Sciences|March 28, 2024
Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian CancerMorgan Bailey, Susan Morand, Rachel Royfman, et al.
Pageof 1